Phreesia Inc (PHR)
22.33
+0.07
(+0.31%)
USD |
NYSE |
May 03, 16:00
22.33
0.00 (0.00%)
After-Hours: 20:00
Phreesia Debt to Equity Ratio: 0.0125 for Jan. 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| January 31, 2024 | 0.0125 |
| October 31, 2023 | 0.00 |
| July 31, 2023 | 0.00 |
| April 30, 2023 | 0.00 |
| January 31, 2023 | 0.0009 |
| October 31, 2022 | 0.0289 |
| July 31, 2022 | 0.0306 |
| April 30, 2022 | 0.0317 |
| January 31, 2022 | 0.0139 |
| October 31, 2021 | 0.0213 |
| July 31, 2021 | 0.0207 |
| Date | Value |
|---|---|
| April 30, 2021 | 0.0191 |
| January 31, 2021 | 0.043 |
| October 31, 2020 | 0.1081 |
| July 31, 2020 | 0.2262 |
| April 30, 2020 | 0.1949 |
| January 31, 2020 | 0.2343 |
| October 31, 2019 | 0.1888 |
| July 31, 2019 | 0.1868 |
| April 30, 2019 | -1.826 |
| January 31, 2019 | -0.1328 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Apr 2023
0.2343
Maximum
Jan 2020
0.0717
Average
0.0289
Median
Oct 2022
Debt to Equity Ratio Benchmarks
| Teladoc Health Inc | 0.6726 |
| American Shared Hospital Services | 0.7773 |
| Novo Integrated Sciences Inc | 0.1478 |
| Astrana Health Inc | 0.4533 |
| Cryo-Cell International Inc | -1.019 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 370.33M |
| Total Liabilities (Quarterly) | 118.88M |
| Shareholders Equity (Quarterly) | 251.45M |
| Current Ratio | 1.777 |
| Net Debt Paydown Yield | 0.08% |